The Sensititre Breakpoint Autoreader system (SBAS) is a broth microdilution method with one to three concentrations of each antibiotic and innovative fluorescence technology to define inhibitory endpoints. We tested 248 gram-negative bacilli and 80 gram-positive cocci using both the rapid (5 h) and overnight (18 h after 18 h of incubation and found good correlation between the two methods for Staphylococcus aureus and members of the family Enterobacteriaceae.
The endpoints of antibiotic susceptibility tests have been traditionally determined by direct visual recognition or turbidimetric measurements of bacterial growth. The Sensititre Autoreader system (Sensititre, Inc., North Andover, Mass.) is unique in that bacterial growth is monitored by measurement of fluorescence produced by the action of bacterial enzymes on fluorogenic substrates present in the broth medium. This principle provides a sensitive means of measuring bacterial growth that permits both full-range MIC and breakpoint susceptibility testing in as little time as 5 h. The Sensititre Breakpoint Autoreader system (SBAS) is a broth dilution method that employs from one to three concentrations of each antibiotic and innovative fluorescence technology to define inhibitory endpoints. The pattern of fluorescence detected by a multichannel fluorometer is analyzed by a microcomputer after either 5 or 18 h of incubation, and a category result of susceptible, intermediate (moderately susceptible), or resistant is assigned for each antibiotic.
Staneck et al. (8) demonstrated very good correlation between full-range MICs determined after overnight incubation with the Autoreader and MICs determined by visual inspection of the Sensititre microdilution plates. In another study, concordance between the results of visually read Sensititre breakpoint panels and the disk diffusion procedure was observed for 88.1% of the comparisons (2) . Recently, Doern et al. ( 3) compared same-day and overnight Sensititre Autoreader breakpoint results with those obtained with the Sensititre manual overnight tests. They found good correlation (94.4%) between the Autoreader and the visually determined endpoints for the members of the family Enterobacteriaceae after 5 h of incubation and for both Pseudomonas aeruginosa (92.2%) and the members of the Enterobacteriaceae (97.2%) after 18 h of incubation.
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after 18 h of incubation and found good correlation between the two methods for Staphylococcus aureus and members of the family Enterobacteriaceae.
In this study, the antibiotic susceptibilities of members of the family Enterobacteriaceae, Pseudomonas spp., staphylococci, and enterococci were assessed by both rapid (5 When the results of the rapid SBAS and the SDD procedures were compared for 19 strains of enterococci, we found 62.3% agreement, with no very major, 14.0% major, and 23.7% minor discrepancies. Penicillin and ampicillin results showed the lowest levels of agreement.
The comparisons of 4,654 overnight SBAS-SDD datum pairs are shown in Table 3 . The agreement between the two test procedures for all organism-antibiotic combinations was 89.2%, with 2.3% very major, 1.3% major, and 7.1% minor discrepancies. When the data were analyzed by organism group, we found 90.4, 78.1, 90.6, and 83.3% agreement for members of the Enterobacteriaceae, Pseudomonas spp., staphylococci, and enterococci, respectively.
The results obtained with the members of the Enterobacteriaceae at 18 h were similar to those obtained with the 5-h SBAS with the following exceptions. There was substantial improvement in the level of agreement with the SDD results for tetracycline, with the number of major discrepancies reduced from 18 to 2%. There were three very major discrepancies recorded for moxalactam at 18 h, as opposed to none for the rapid procedure.
Overnight incubation of Pseudomonas spp. improved the levels of agreement for all antibiotics between the SBAS and the SDD to 78.1%. Piperacillin was the drug for which the greatest improvement was demonstrated, with 2.1, 0, and 3.0% very major, major, and minor errors, respectively. The number of very major discrepancies that occurred with the Pseudomonas spp.-moxalactam combination was greater with the overnight SBAS procedure, as noted previously for the members of the Enterobacteriaceae.
An overall improvement was also seen at 18 h for the gram-positive cocci tested. The results obtained for clindamycin and erythromycin with the staphylococci were in close agreement with the SDD, 100 and 94.2%, respectively. The number of very major discrepancies recorded for cefazolin and cephalothin was substantially reduced. Although overnight incubation reduced the number of major discrepancies that occurred with oxacillin from eight to one, the number of very major errors increased from two to four. The 18-h SBAS results for augmentin and staphylococci showed only 78.8% agreement with the SDD results; however, all discrepancies were minor. Although there was some improvement, sulfisoxazole also proved to be a problem for the overnight SBAS procedure, with 3.8% very major, 34.6% major, and no minor discrepancies. Valid breakpoint results were obtained after 18 h of incubation for only 15 The reproducibility and accuracy of the SBAS results were determined by daily testing of two strains used routinely for quality control of the SDD method. E. coli (ATCC 25922) was tested 27 times by the 5-h SBAS procedure. There were 26 (5.6%) discrepant results found for the 459 tests. Twenty-three minor errors with ampicillin, one minor error with carbenicillin, one major error with chloramphenicol, and one major error with sulfamethoxazole were noted. The same strain was tested 26 times by the 18-h SBAS procedure. There were 23 discrepant results: 22 minor errors with ampicillin and one minor error with cephalothin.
S. aureus (ATCC 25923) was tested 24 times by the rapid SBAS procedure, and there were 31 (8.6%) discrepancies recorded for 360 tests. We found 28 major errors (sulfisoxazole, 18; TMP-SMZ, 3; and 1 each for penicillin, ampicillin, chloramphenicol, gentamicin, nitrofurantoin, cefazolin, and oxacillin) and 3 minor errors (1 each for tetracycline, TMP-SMZ, and amoxicillin-clavulanic acid). With the overnight SBAS procedure, we found 29 (7.2%) discrepancies for 405 tests. There were 28 major errors (sulfisoxazole, 25; and TMP-SMZ, 3) and 1 minor error with TMP-SMZ. DISCUSSION In this study, we compared the performance of both the rapid and overnight SBAS procedures with the SDD for bacterial species commonly subjected to susceptibility testing in clinical laboratories. To our knowledge, this study is the first published comparison of the SBAS with an accepted reference test method. A previous study (2) demonstrated good correlation between the results of visually read Sensititre breakpoint plates and the SDD method. Subsequent evaluations of the Autoreader system (3, 8, 9) have compared the results with visually determined results by using microdilution plates prepared by the same manufacturer. This approach is biased toward the SBAS and provides limited information regarding the performance of the system relative to a reference method.
No consensus exists among clinical microbiologists as to an acceptable level of agreement between the results of different susceptibility test methods. Thornsberry (10) proposed that complete correlation between a new test method and a reference method should be >90% and that the combined major and very major discrepancies attributable to the new system should be <5%. Sherris and Ryan (7) recommended that the overall agreement between the results of the two methods should be .95% and that the very major errors should not exceed 1.5%.
If we apply the criteria proposed by Thornsberry to our data, we find that both the 5-and 18-h SBAS procedures are acceptable alternatives to the SDD for members of the Enterobacteriaceae if nitrofurantoin and tetracycline are excluded. The overnight SBAS procedure is also found to be acceptable for staphylococci. However, the SBAS results with Pseudomonas spp. and enterococci showed unacceptably low levels of agreement with the reference method. We included selected strains as well as recent clinical isolates in our evaluation to ensure that the system was challenged with most of the clinically relevant antibiotic resistance determinants. Because of this, our study may represent a more severe test of the SBAS than the previously published evaluation.
A disproportionate percentage of very major discrepancies that occurred between the SBAS and the SDD were with nitrofurantoin and tetracycline when tested against members of the Enterobacteriaceae. The nitrofurantoin very major discrepancies occurred almost exclusively (90%) with Proteus spp., Providencia spp., M. morganii, and Serratia spp., bacteria generally considered resistant to nitrofurantoin in vivo (12) . The very major discrepancies between the rapid SBAS and the SDD results for tetracycline occurred with 22 Proteus mirabilis, 5 Serratia spp., 4 E. coli, 2 Enterobacter aerogenes, and 1 each Klebsiella pneumoniae, Salmonella typhimurium, and Shigella dysenteriae. The problem with the rapid tetracycline results most likely has its origin in the algorithm used to interpret the fluorescent signals at 5 h because there was a dramatic reduction in the number of very major discrepancies recorded for tetracycline with the overnight SBAS procedure.
The problem with nitrofurantoin appears to be a fundamental one in that poor correlation with the SDD method was found for all Sensititre procedures regardless of the length of incubation or how the endpoints were determined. Doern et al. (2) also noted a large percentage of very major discrepancies occurring with members of the Enterobacteriaceae and nitrofurantoin in their evaluation of manually read Sensititre breakpoint plates. They attributed the discrepancies to false-resistant results by SDD since the breakpoint results were confirmed by the Sensititre full-range MIC procedure in 14 of 17 cases.
Most of the minor discrepancies for members of the Enterobacteriaceae occurred with five drugs: ampicillin, cephalothin, carbenicillin, piperacillin, and chloramphenicol. Minor discrepancies can result from differences between the methods in technical performance or interpretive criteria. For ampicillin, carbenicillin, and pipericillin, substantial differences exist between the concentrations of drug selected for incorporation in the breakpoint panels and the National Committee for Clinical Laboratory Standards equivalent MIC breakpoints for the SDD categories (5). These differences probably help explain the large number of minor discrepancies that occurred between the two methods, especially for ampicillin.
The combination of ampicillin and Enterobacter spp. has proved problematic for a number of 4-to 8-h antibiotic susceptibility test systems (4, 11) . The problems have been mostly false-susceptible results with the rapid systems. We found no false ampicillin susceptibility among the 23 resistant Enterobacter spp. we tested with the 5-h SBAS.
Reliable detection of ORSA has been difficult for most rapid susceptibility testing systems (10) . Systems that require incubation for 4 to 8 h do not allow enough time for the growth of heteroresistant strains, and the result is often false-susceptibility. We found excellent correlation (95%) between the oxacillin results of the rapid SBAS and the SDD for oxacillin-susceptible S. aureus and ORSA. One ORSA was not recognized in either the rapid or overnight SBAS procedure. The AGPB test panel used in this study contained oxacillin as the representative semisynthetic penicillin and NaCI at a final concentration of 2% to enhance detection of heteroresistant strains (6). Staneck et al. (9) found that only 1 of 8 (12.5%) of methicillin-resistant S. aureus tested successfully with the rapid Autoreader full-range MIC procedure. However, the microdilution plates contained methicillin without the increased concentration of NaCl.
False-susceptibility to the cephalosporins for ORSA occurred more frequently with the SBAS system than with the SDD method. However, all ORSA should be considered resistant to the cephalosporins regardless of the results of in vitro susceptibility tests.
The coagulase-negative staphylococci generated sufficient fluorescent signal in the growth control wells for a valid test VOL. 26, 1988 on July 9, 2017 by guest http://jcm.asm.org/ Downloaded from 1084 NOLTE ET AL. breakpoint in only 36.4 and 68.1% of the 5-and 18-h SBAS tests, respectively. This appeared to result from poor growth in the broth medium rather than failure to liberate fluorogen since visual reading at 18 h often showed scant bacterial pellets in the growth control wells. Staneck et al. (9) found that the Autoreader gave MIC results for only 4 of 42 (9.5%) coagulase-negative staphylococci after 5 h of incubation.
The SBAS results of sulfisoxazole testing for staphylococci were unreliable at both 5 and 18 h of incubation. Susceptibility testing of sulfisoxazole is very medium dependent; however, testing on Mueller-Hinton agàr works reasonably well providing an endpoint of 80% inhibition is used (1) . The endpoints in broth microdilution methods may be difficult to define because even sensitive strains may go through several growth generations before endogenous and exogenous folate is depleted.
The SBAS is mechanically reliable, and we experienced no major problems with the automated inoculator, fluorometer, or computer during the 5-month evaluation period. The reproducibility and accuracy of the SBAS was assessed by repeated daily testing of E. coli (ATCC 25922) and S. aureus (ATCC 25923). With the exception of ampicillin, the results with E. coli were highly reproducible and accurate. The quality control range of MICs for this strain is 2.0 to 8.0 ug/lml (6) . Since the concentrations of ampicillin in the APB3A plate were 1.0 and 16 ,ug/ml, it follows that the ampicillin results were consistently interpreted by the system as intermediate. Accuracy was also a problem for sulfisoxazole and staphylococci. As discussed above, defining inhibitory endpoints in broth dilution tests with sulfisoxazole is often difficult.
This study demonstrates the considerable potential that fluorogenics holds for antibiotic susceptibility testing. The SBAS has several features that distinguish it from other automated systems. It offers the user the option of performing either same-day or overnight susceptibility testing with the same instrument. In addition, plates that are incubated overnight can be read visually. Visual reading serves as a backup in case of instrument malfunction because the fluorescence assay does not interfere with bacterial growth. Inhibitory endpoints obtained by breakpoint microdilution testing may be more distinct and easier to interpret than those obtained by either the SDD method or full-range MICs (2) . The SBAS microdilution plates contain dehydrated, stabilized antibiotics, and as a result, the plate may be stored for long periods at room temperature. Finally, the cost per test is kept to a minimum by incorporation of three separate antibiotic panels in each microdilution plate.
